© Martin Houde 2016
Bodycad Receives FDA 510K Clearance for Personalized Unicompartmental Knee System (press release)
Bodycad website
QUEBEC CITY, March 29, 2017 /PRNewswire/ -- Bodycad announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Bodycad Unicompartmental Knee System, enabling the commercial launch of this truly personalized orthopaedic restoration. Bodycad is the first Canadian company to receive FDA clearance for a joint reconstruction implant system.
Bodycad's revolutionary Unicompartmental Knee System is designed to optimize personalized restoration of the patient's unique anatomical features and kinematics. The system is based on proprietary 3D rendering of medical images of the patient's anatomy. The restoration is delivered as a "procedure in a box" that completely revolutionizes the way orthopaedic implant and instrument applications are delivered and utilized in the operating room environment.
"The personalized restoration is created only after proper acquisition of data from the patient on an individualized level," says Etienne Belzile, MD, orthopaedic surgeon and assistant professor at Laval University. "The ...
